From turning stone on another board: This is a
Post# of 148175
(Total Views: 607)
Posted On: 12/21/2020 6:42:42 PM
From turning stone on another board:
This is a response from D. Scott Kelly of CytoDyn after I emailed him to ask if LL would work on the new strain of covid.
Original Message
From: Scott Kelly <skelly@cytodyn.com>
To: xxxxxxxxxxx
Cc: "Nader Z. Pourhassan" <npourhassan@cytodyn.com>
Date: 12/21/2020 9:19 AM
Subject: leronlimab
Robert,
The mutation would not affect leronlimab’s ability to work on the CCR5 pathway.
Best,
Scott A. Kelly, M.D.
This is a response from D. Scott Kelly of CytoDyn after I emailed him to ask if LL would work on the new strain of covid.
Original Message
From: Scott Kelly <skelly@cytodyn.com>
To: xxxxxxxxxxx
Cc: "Nader Z. Pourhassan" <npourhassan@cytodyn.com>
Date: 12/21/2020 9:19 AM
Subject: leronlimab
Robert,
The mutation would not affect leronlimab’s ability to work on the CCR5 pathway.
Best,
Scott A. Kelly, M.D.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼